Ambulatory Cardiac Monitoring Market Size
| Study Period | 2019 - 2029 |
| Market Size (2024) | USD 6.91 Billion |
| Market Size (2029) | USD 10.75 Billion |
| CAGR (2024 - 2029) | 9.23 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Ambulatory Cardiac Monitoring Market Analysis
The Ambulatory Cardiac Monitoring Market size is estimated at USD 6.91 billion in 2024, and is expected to reach USD 10.75 billion by 2029, growing at a CAGR of 9.23% during the forecast period (2024-2029).
- COVID-19 had a significant impact on the growth of the market during the pandemic period. The usage of cardiac implantable devices to monitor patient conditions remotely during the lockdown was one of the major driving factors. According to a National Center for Biotechnology Information (NCBI) article published in March 2022, the frequency of in-office was significantly lower during the pandemic. Nearly two-thirds of survey participants established new remote monitoring connections for cardiac implantable electronic devices before the pandemic, with 33.3% delivering remote monitoring connections to the patient's home address and the remaining 32.1% activating remote monitoring connections during an in-office visit. Thus, there was an increased demand for implantable cardiac devices during the pandemic, contributing to the market's growth.
- However, the rise in the adoption rate for ambulatory cardiac monitoring during the pandemic and the increase in outpatient visits during the post-pandemic period is expected to contribute to the market's growth over the coming five years. The ambulatory cardiac monitoring market is driven by an increase in the prevalence of heart diseases, a growing aging population who are very susceptible to coronary heart diseases, and technological advancements in cardiac monitoring devices for improved efficacy.
- According to data published by the British Heart Foundation (BHF) in August 2022, around 7.6 million people live with heart and circulatory diseases in the United Kingdom. Such increasing prevalence of cardiovascular diseases, which led to a growing need for monitoring the patient condition, is expected to drive the growth of the ambulatory cardiac monitoring market.
- Similarly, as per an article published by the British Heart Foundation (BHF) in February 2021, around 371,000 heart procedures and operations were performed in England in 2020. In addition, an NCBI article published in October 2020 stated that approximately 40,000 children in the United States undergo congenital heart surgery each year. Such an increasing number of cardiovascular surgeries a to the extensive usage of ambulatory cardiac monitoring devices for constant monitoring of the patient's heart condition, thus driving the market growth.
- Also, the advanced product launches and strategic initiatives by the key market players are expected to drive the market's growth during the forecast period. For instance, in June 2021, AliveCor acquired the independent diagnostic testing facility (IDTF) CardioLabs, one of the leading monitoring and cardiac diagnostic service provider. The acquisition is a cornerstone of AliveCor's mission to extend its comprehensive cardiological services to patients prescribed monitoring devices by their healthcare providers.
- Thus, the factors such as an increase in the prevalence of heart diseases and increasing product launches are expected to drive the market growth during the forecast period. However, high costs associated with the monitoring and stringent regulatory procedures may act as restraints to the growth of the ambulatory cardiac monitoring market over the forecast period.
Ambulatory Cardiac Monitoring Market Trends
This section covers the major market trends shaping the Ambulatory Cardiac Monitoring Market according to our research experts:
ECG Monitors is Expected to Hold a Significant Share in the Ambulatory Cardiac Monitoring Market Over the Forecast Period.
- As there is an increase in the incidence of cardiovascular diseases (CVD), long-term ECG monitoring is necessary, thereby contributing to the growth of the ECG monitor segment. Usually, this procedure is possible in hospitals. However, with the introduction of wireless ECG, doctors can monitor and diagnose patients remotely and on time. There are two different types of ECG monitors available in the market: ECG Monitors and diagnostic ECG systems.
- Several market players developed wireless ECG monitors. These devices can be used for continuously monitoring patients suffering from CVD and for detecting problems when they are usually easier to treat while avoiding life-threatening and expensive emergency admissions.
- Frequent product launches in the respective segment are one of the major factors driving the market. For instance, in October 2022, Dozee planned to launch an ambulatory electrocardiogram (ECG) path to monitor patients with cardiovascular disease. This easy-to-use ECG patch augments the company's artificial intelligence (AI)-powered remote patient monitoring system to play a vital role in assisting healthcare professionals in identifying early signs of cardiac disorders. Also, in January 2022, Philips launched a 12-lead electrocardiogram (ECG) solution for use at home in decentralized clinical trials in January 2022.
- Similarly, in September 2021, Vitsa Health, in partnership with CradioScan Lts, launched an innovative ambulatory ECG monitoring service that allows patients to self-refer to an ECG monitor and apply it from the comfort of their homes. Thus, the factors such as practical and long-term ECG monitoring coupled with frequent product launches are expected to drive the ambulatory cardiac monitoring market during the forecast period.
North America is Expected to Dominate the Ambulatory Cardiac Monitoring Market Over the Forecast Period.
- The North American region is expected to witness significant growth due to the increasing prevalence of cardiovascular disease, growing technological advancements, rapid economic growth, and favorable government initiatives. For instance, the data published by Organization for Economic Co-operation and Development in 2021 mentioned that the geriatric population aged over 65 or over in the United States is 16.8%. Such an increase in the geriatric population leads to the rising demand for cardiac pacemakers, thereby contributing to market growth.
- Additionally, increasing product approvals and product launches are expected to reinforce growth prospects in the North American region over the forecast period. For instance, in January 2022, Medilynx cardiac monitoring received a broad patent in the United States for continuous ECG streaming, analysis, and monitoring from a remote location. Also, in May 2021, Vital Connect launched its latest cardiac monitoring patch, the VitalPatch RTM, for patients who require extended Holter monitoring.
- Furthermore, in July 2021, Abbot launched the JotDx, the company's insertable cardiac monitor, in the United States. The Jot Dx ICM gives clinicians and hospitals control over how they manage the flow of information through a unique feature to view heart conditions. Hence, the increasing prevalence of cardiovascular diseases, rising demand for effective ambulatory cardiac monitoring, and product launches are expected to drive market growth in this region during the forecast period.
Ambulatory Cardiac Monitoring Industry Overview
The ambulatory cardiac monitoring market is slightly fragmented and focused owing to the presence of a large number of market players. The competitive landscape includes an analysis of a few international as well as local companies which hold market shares and are well known. The key market players are Medtronic, Abbott Laboratories, Boston Scientific Corporation, GE Healthcare, iRhythm technologies Inc, Biotronik, and others.
Ambulatory Cardiac Monitoring Market Leaders
-
Medicomp Inc.
-
iRhythm Technologies, Inc.
-
BioTelemetry, Inc.
-
Medtronic Plc
-
GE Healthcare
*Disclaimer: Major Players sorted in no particular order
Ambulatory Cardiac Monitoring Market News
- August 2022: Smart Cardia launched the 7 L patch, their 7-lead Cardiac monitoring patch in India. This state-of-the-art patch monitor combines medical wearable technology with artificial intelligence (AI) to provide predictive and personalized patient insights through remote monitoring.
- February 2022: AlveCor launched the KardiaMobile card, the slimmest most convenient personal ECG device. KardiaMobile card delivers the most sophisticated AI in the most convenient form factor.
Ambulatory Cardiac Monitoring Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Growing Incidences of Cardiovascular Diseases
- 4.2.2 Advances in Ambulatory Cardiac Monitoring Devices
-
4.3 Market Restraints
- 4.3.1 Risk of Infection Due to Implantable Monitoring Devices
- 4.3.2 Price Sensitive Market
-
4.4 Porter's Five Force Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD million)
-
5.1 By Device Type
- 5.1.1 ECG Monitors
- 5.1.2 Event Recorders
- 5.1.3 Implantable Cardiac Loop Recorders
- 5.1.4 Mobile Cardiac Telemetry
- 5.1.5 Others
-
5.2 Geography
- 5.2.1 North America
- 5.2.1.1 United States
- 5.2.1.2 Canada
- 5.2.1.3 Mexico
- 5.2.2 Europe
- 5.2.2.1 Germany
- 5.2.2.2 United Kingdom
- 5.2.2.3 France
- 5.2.2.4 Italy
- 5.2.2.5 Spain
- 5.2.2.6 Rest of Europe
- 5.2.3 Asia Pacific
- 5.2.3.1 China
- 5.2.3.2 Japan
- 5.2.3.3 India
- 5.2.3.4 Australia
- 5.2.3.5 South Korea
- 5.2.3.6 Rest of Asia-Pacific
- 5.2.4 Middle East and Africa
- 5.2.4.1 GCC
- 5.2.4.2 South Africa
- 5.2.4.3 Rest of Middle East and Africa
- 5.2.5 South America
- 5.2.5.1 Brazil
- 5.2.5.2 Argentina
- 5.2.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 Medtronic plc
- 6.1.2 Abbott Laboratories
- 6.1.3 Boston Scientific Corporation
- 6.1.4 GE Healthcare
- 6.1.5 iRhythm Technologies Inc
- 6.1.6 Biotronik
- 6.1.7 Schiller
- 6.1.8 Medicomp Inc.
- 6.1.9 Koninklijke Philips N.V.
- 6.1.10 Applied Cardiac System
- 6.1.11 MicroPort
- 6.1.12 Nihon Kohden Corporation
- 6.1.13 Asahi Kasei Medical Co., Ltd
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Ambulatory Cardiac Monitoring Industry Segmentation
As per the scope of the report, ambulatory cardiac monitoring is a way to watch and record the electrical activity of your heart. It is done for daily activities. Most of the recording devices are about the size of a cell phone. Each ambulatory cardiac monitoring device has features that make them better suited to handle different monitoring needs. The patient's needs will ultimately determine which device will be used to get an accurate diagnosis.
The ambulatory cardiac monitoring market is segmented by device type (EGC monitors, event recorders, implantable cardiac loop recorders, mobile cardiac telemetry, and others) and geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally.
The report offers the value (in USD million) for the above segments.
| By Device Type | ECG Monitors | |
| Event Recorders | ||
| Implantable Cardiac Loop Recorders | ||
| Mobile Cardiac Telemetry | ||
| Others | ||
| Geography | North America | United States |
| Canada | ||
| Mexico | ||
| Geography | Europe | Germany |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Rest of Europe | ||
| Geography | Asia Pacific | China |
| Japan | ||
| India | ||
| Australia | ||
| South Korea | ||
| Rest of Asia-Pacific | ||
| Geography | Middle East and Africa | GCC |
| South Africa | ||
| Rest of Middle East and Africa | ||
| Geography | South America | Brazil |
| Argentina | ||
| Rest of South America |
Ambulatory Cardiac Monitoring Market Research FAQs
How big is the Ambulatory Cardiac Monitoring Market?
The Ambulatory Cardiac Monitoring Market size is expected to reach USD 6.91 billion in 2024 and grow at a CAGR of 9.23% to reach USD 10.75 billion by 2029.
What is the current Ambulatory Cardiac Monitoring Market size?
In 2024, the Ambulatory Cardiac Monitoring Market size is expected to reach USD 6.91 billion.
Who are the key players in Ambulatory Cardiac Monitoring Market?
Medicomp Inc., iRhythm Technologies, Inc., BioTelemetry, Inc., Medtronic Plc and GE Healthcare are the major companies operating in the Ambulatory Cardiac Monitoring Market.
Which is the fastest growing region in Ambulatory Cardiac Monitoring Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Ambulatory Cardiac Monitoring Market?
In 2024, the North America accounts for the largest market share in Ambulatory Cardiac Monitoring Market.
What years does this Ambulatory Cardiac Monitoring Market cover, and what was the market size in 2023?
In 2023, the Ambulatory Cardiac Monitoring Market size was estimated at USD 6.33 billion. The report covers the Ambulatory Cardiac Monitoring Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Ambulatory Cardiac Monitoring Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Medical Telemetry Industry Report
Statistics for the 2024 Medical Telemetry market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Medical Telemetry analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
